Finance

Beta
Lists
NSB:ASX
Neuroscientific Biopharmaceuticals Ltd
A$0.086
-5.49%
(-0.0050) 1D
Jun 4, 3:51:04 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for NSB...
Open
A$0.10
High
A$0.10
Low
A$0.09
Mkt. cap
29.55M
Avg. vol.
340.38K
Volume
313.52K
52-wk high
A$0.26
52-wk low
A$0.05
EPS
-A$0.02
Shares outstanding
389.72M
Open
A$0.10
High
A$0.10
Low
A$0.09
Mkt. cap
29.55M
Avg. vol.
340.38K
Volume
313.52K
52-wk high
A$0.26
52-wk low
A$0.05
EPS
-A$0.02
Shares outstanding
389.72M
News stories
From sources across the web
About Neuroscientific Biopharmaceuticals Ltd
CEO-
Employees-
Founded2002
Headquarters-
SectorBiotechnology
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
158.95K
158.95K
Cost of goods sold
-237.00
-237.00
23.53K
23.53K
Cost of revenue
-237.00
-237.00
23.53K
23.53K
Research and development expenses
50.20K
50.20K
225.61K
225.61K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
301.84K
301.84K
409.06K
409.06K
Operating expense
774.66K
774.66K
1.04M
1.04M
Total operating expenses
774.42K
774.42K
1.07M
1.07M
Operating income
-774.42K
-774.42K
-908.64K
-908.64K
Other non operating income
-
-
-
-
EBT including unusual items
-738.98K
-738.98K
-849.71K
-849.71K
EBT excluding unusual items
-738.98K
-738.98K
-849.71K
-849.71K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-738.98K
-738.98K
-849.71K
-849.71K
Net profit margin
-
-
-534.56%
-534.56%
Earnings per share
-
-
-
-
Interest and investment income
35.47K
35.47K
59.20K
59.20K
Interest expense
-24.00
-24.00
-263.00
-263.00
Net interest expenses
35.44K
35.44K
58.94K
58.94K
Depreciation and amortization charges
1.83K
1.83K
383.00
383.00
EBITDA
-750.80K
-750.80K
-597.26K
-597.26K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more